COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,097 Articles (22,658 medRxiv, 8,439 bioRxiv)

Most recent first Previous |  Page 1335: Articles 13341-13350  | Next

Cell-Mediated and Humoral Immune Response to 2-Dose SARS-CoV2 mRNA vaccination in Immunocompromised patient population
Ramanathan, M., Murugesan, K., Yang, L. M., Costales, C., Bulterys, P. L., Schroers-Martin, J., Alizadeh, A. A., Boyd, S. D., Brown, J. M., Nadeau, K. C., Nadimpalli, S. S., Wang, A. X., Busque, S., Pinsky, B. A., Banaei, N.
10.1101/2021.07.21.21260921 — Posted: 2021-07-23
Reduced neutralizing activity of post-SARS-CoV-2 vaccination serum against variants B.1.617.2, B.1.351, B.1.1.7+E484K and a sub-variant of C.37
Carreno, J. M., Alshammary, H., Singh, G., Raskin, A., Amanat, F., Amoako, A., Gonzalez-Reiche, A. S., van de Guchte, A., PARIS study group, , Srivastava, K., Sordillo, E. M., Sather, D. N., van Bakel, H., Krammer, F., Simon, V.
10.1101/2021.07.21.21260961 — Posted: 2021-07-23
New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations
Degenhardt, F., Ellinghaus, D., Juzenas, S., Lerga-Jaso, J., Wendorff, M., Maya-Miles, D., Uellendahl-Werth, F., ElAbd, H., Ruehlemann, M. C., Arora, J., oezer, O., Lenning, O. B., Myhre, R., Vadla, M. S., Wacker, E. M., Wienbrandt, L., Blandino Ortiz, A., de Salazar, A., Garrido Chercoles, A., Palom, A., Ruiz, A., Mantovani, A., Zanella, A., Rygh Holten, A., Mayer, A., Bandera, A., Cherubini, A., Protti, A., Aghemo, A., Gerussi, A., Popov, A., Ramirez, A., Braun, A., Nebel, A., Barreira, A., Lleo, A., Teles, A., Kildal, A. B., Biondi, A., Ganna, A., Gori, A., Glueck, A., Lind, A., Hinney, A., Carreras Nolla, A., Fracanzani, A. L., Cavallero, A., Dyrhol-Riise, A. M., Ruello, A., Julia, A., Muscatello, A., Pesenti, A., Voza, A., Rando-Segura, A., Solier, A., Cortes, B., Mateos, B., Nafria-Jimenez, B., Schaefer, B., Jensen, B., Bellinghausen, C., Maj, C., Ferrando, C., de la Horrra, C., Quereda, C., Skurk, C., Thibeault, C., Scollo, C., Herr, C., Spinner, C. D., Lange, C., Hu, C., Lehmann, C., Cappadona, C., Azuure, C., COVICAT study group, , Covid-19 Aachen Study (COVAS), , Bianco, C., Sancho, C., Lihaug Hoff, D. A., Galimberti, D., Prati, D., Haschka, D., Jimenez, D., Pestana, D., Toapanta, D., Azzolini, E., Scarpini, E., Helbig, E. T., Urrechaga, E., Paraboschi, E. M., Pontali, E., Reverter, E., Calderon, E. J., Navas, E., Solligard, E., Contro, E., Arana, E., Garcia, F., Garcia Sanchez, F., Ceriotti, F., Martinelli-Boneschi, F., Peyvandi, F., Kurth, F., Blasi, F., Malvestiti, F., Medrano, F. J., Mesonero, F., Rodriguez-Frias, F., Hanses, F., Mueller, F., Bellani, G., Grasselli, G., Pezzoli, G., Costantino, G., Albano, G., Bellelli, G., Citerio, G., Foti, G., Lamorte, G., Neb, H., My, I., Kurth, I., Hernandez, I., Pink, I., de Rojas, I., Galvan-Femenia, I., Holter, J. C., Egil Afset, J. E., Heyckendorf, J., Damas, J., Rybniker, J. K., Altmueller, J., Ampuero, J., Banales, J. M., Ramon Badia, J., Dopazo, J., Schneider, J., Bergan, J., Barretina, J., Walter, J., Hernandez Quero, J., Goikoetxea, J., Delgado, J., Guerrero, J. M., Fazaal, J., Kraft, J., Schroeder, J., Risnes, K., Banasik, K., Mueller, K. E., Gaede, K. I., Garcia-Etxebarria, K., Tonby, K., Heggelund, L., Izquierdo-Sanchez, L., Bettini, L. R., Sumoy, L., Sander, L. E., Lippert, L. J., Terranova, L., Nkambule, L., Knopp, L., Gustad, L. T., Garbarino, L., Santoro, L., Tellez, L., Roade, L., Ostadreza, M., Intxausti, M., Kogevinas, M., Riveiro-Barciela, M., Berger, M. M., Niemi, M. E. K., Gutierrez-Stampa, M. A., Valsecchi, M. G., Hernandez-Tejero, M., Vehreschild, M. J. G. T., Manunta, M., D'Angio, M., Cazzaniga, M., Grimsrud, M. M., Cornberg, M., Noethen, M. M., Marquie, M., Castoldi, M., Cordioli, M., Cecconi, M., D'Amato, M., Augustin, M., Tomasi, M., Boada, M., Dreher, M., Seilmaier, M. J., Joannidis, M., Wittig, M., Mazzocco, M., Rodriguez-Gandia, M., Imaz Ayo, N., Blay, N., Chueca, N., Montano, N., Ludwig, N., Marx, N., Martinez, N., Norwegian SARS-CoV-2 Study group, , Cornely, O. A., Witzke, O., Palmieri, O., Pa COVID-19 Study Group, , Faverio, P., Bonfanti, P., Tentorio, P., Castro, P., Rodrigues, P. M., Espana, P. P., Hoffmann, P., Rosenstiel, P., Schommers, P., Suwalski, P., de Pablo, R., Ferrer, R., Bals, R., Gualtierotti, R., Gallego-Duran, R., Nieto, R., Carpani, R., Morilla, R., Badalamenti, S., Haider, S., Ciesek, S., May, S., Bombace, S., Marsal, S., Pigazzini, S., Klein, S., Rolker, S., Pelusi, S., Wilfling, S., Bosari, S., Brunak, S., Raychaudhuri, S., Schreiber, S., Heilmann-Heimbach, S., Aliberti, S., Ripke, S., Dudman, S., The Humanitas COVID-19 Task Forse, , The Humanitas Gavazzeni COVID-19 Task Force, , Bahmer, T., Eggermann, T., Illig, T., Brenner, T., Feldt, T., Folseraas, T., Cejudo, T. G., Landmesser, U., Protzer, U., Hehr, U., Rimoldi, V., Skogen, V., Keitel, V., Kopfnagel, V., Friaza, V., Andrade, V., Moreno, V., Poller, W., Farre, X., Wang, X., Khodamoradi, Y., Karadeniz, Z., Latiano, A., Goerg, S., Bacher, P., Koehler, P., Tran, F., Zoller, H., Schulte, E. C., Heidecker, B., Ludwig, K. U., Fernandez, J., Romero-Gomez, M., Albillos, A., Invernizzi, P., Buti, M., Duga, S., Bujanda, L., Hov, J. R., Lenz, T. L., Asselta, R., de Cid, R., Valenti, L., Karlsen, T. H., Caceres, M., Franke, A.
10.1101/2021.07.21.21260624 — Posted: 2021-07-23
Present knowledge, attitude, practice, and fear level of Bangladeshi people towards covid-19 after one year of the pandemic situation: a web-based cross-sectional study.
Rupok, T. A., Dey, S., Agarwala, R., Islam, M. N., Bostami, B.
10.1101/2021.07.19.21260721 — Posted: 2021-07-23
Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination
Pastorino, R., Pezzullo, A. M., Villani, L., Causio, F. A., Axfors, C., Contopoulos-Ioannidis, D. G., Boccia, S., Ioannidis, J. P. A.
10.1101/2021.07.20.21260842 — Posted: 2021-07-23
Comparative profiles of SARS-CoV-2 Spike-specific milk antibodies elicited by COVID-19 vaccines currently authorized in the USA
Fox, A., DeCarlo, C., Yang, X., Norris, C., Powell, R. L.
10.1101/2021.07.19.21260794 — Posted: 2021-07-23
Recruitment of highly functional SARS-CoV-2-specific CD8+ T cell receptors mediating cytotoxicity of virus-infected target cells in non-severe COVID-19
Wagner, K. I., Mateyka, L. M., Jarosch, S., Grass, V., Weber, S., Schober, K., Hammel, M., Burrell, T., Kalali, B., Poppert, H., Beyer, H., Schambeck, S., Holdenrieder, S., Stroetges-Achatz, A., Haselmann, V., Neumaier, M., Erber, J., Priller, A., Yazici, S., Roggendorf, H., Odendahl, M., Tonn, T., Witter, K., Dick, A., Mijocevic, H., Protzer, U., Knolle, P. A., Pichlmair, A., Crowell, C. S., Gerhard, M., D Ippolito, E., Busch, D. H.
10.1101/2021.07.20.21260845 — Posted: 2021-07-23
BNT162b2 Vaccination efficacy is marginally affected by the SARS-CoV-2 B.1.351 variant in fully vaccinated individuals.
Huppert, A., Mor, O., Zuckerman, N. S., Hazan, I., Fluss, R., Ash, N., Ginish, N., Mendelson, E., Alroy-Price, S., Freedman, L. S.
10.1101/2021.07.20.21260833 — Posted: 2021-07-23
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic analysis of coroners case reports from the COVID-19 pandemic
Swift, B., Heneghan, C., Aronson, J. K., Howard, D., Richards, G. C.
10.1101/2021.07.15.21260589 — Posted: 2021-07-23
Increase in ventilatory ratio indicates progressive alveolar damage and suggests poor prognosis in severe COVID-19: A single-center retrospective observational study.
Kaku, N., Nakagama, Y., Shirano, M., Shinomiya, S., Shimazu, K., Yamazaki, K., Maehata, Y., Morita, R., Nitahara, Y., Yamamoto, H., Mizobata, Y., Kido, Y.
10.1101/2021.07.20.21260754 — Posted: 2021-07-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).